New functionality aligns with EMA, FDA, and ICH E6(R3) expectations for documented investigator review, endorsement, and sign-off of participant data MALVERN, Pa., Oct. 29, 2025 (GLOBE NEWSWIRE) -- ...
MALVERN, Pa., Oct. 29, 2025 (GLOBE NEWSWIRE) — YPrime, a proven leader in clinical trial technology, today announced the launch of its Advanced eCOA Oversight functionality—a key enhancement to its ...
New functionality aligns with EMA, FDA, and ICH E6, a proven leader in clinical trial technology, today announced the launch of its Advanced eCOA Oversightfunctionality-a key enhancement to its eCOA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results